These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 21298288

  • 1. Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy.
    Xu ZY, Jin CJ, Zhou CC, Wang ZQ, Zhou WD, Deng HB, Zhang M, Su W, Cai XY.
    J Cancer Res Clin Oncol; 2011 Jul; 137(7):1117-22. PubMed ID: 21298288
    [Abstract] [Full Text] [Related]

  • 2. [Clinical study on treatment of advanced non-small-cell lung cancer with Chinese herbal medicine in different stages combined with chemotherapy].
    Xu ZY, Jin CJ, Shen DY.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Oct; 27(10):874-8. PubMed ID: 17990450
    [Abstract] [Full Text] [Related]

  • 3. [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial].
    Yan GY, Xu ZY, Deng HB, Wan ZY, Zhang L, Zhu JY.
    Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):525-30. PubMed ID: 21565138
    [Abstract] [Full Text] [Related]

  • 4. Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
    Comella P, Frasci G, De Cataldis G, Panza N, Cioffi R, Curcio C, Belli M, Bianco A, Ianniello G, Maiorino L, Della Vittoria M, Perchard J, Comella G.
    Br J Cancer; 1996 Dec; 74(11):1805-11. PubMed ID: 8956797
    [Abstract] [Full Text] [Related]

  • 5. Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study).
    Kreuter M, Vansteenkiste J, Fischer JR, Eberhardt WE, Zabeck H, Kollmeier J, Serke M, Frickhofen N, Reck M, Engel-Riedel W, Neumann S, Thomeer M, Schumann C, De Leyn P, Graeter T, Stamatis G, Griesinger F, Thomas M, TREAT investigators.
    J Thorac Oncol; 2016 Jan; 11(1):85-93. PubMed ID: 26762743
    [Abstract] [Full Text] [Related]

  • 6. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
    Komaki R, Scott CB, Sause WT, Johnson DH, Taylor SG, Lee JS, Emami B, Byhardt RW, Curran WJ, Dar AR, Cox JD.
    Int J Radiat Oncol Biol Phys; 1997 Oct 01; 39(3):537-44. PubMed ID: 9336129
    [Abstract] [Full Text] [Related]

  • 7. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ, Fournel P, Bohas CH, Fortune IC, Chatte G.
    Semin Oncol; 1996 Apr 01; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [Abstract] [Full Text] [Related]

  • 8. Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer.
    Masters GA, Hahn EA, Shevrin DH, Kies MS.
    Lung Cancer; 2003 Feb 01; 39(2):221-6. PubMed ID: 12581577
    [Abstract] [Full Text] [Related]

  • 9. Phase II randomized trial of erlotinib or vinorelbine in chemonaive, advanced, non-small cell lung cancer patients aged 70 years or older.
    Chen YM, Tsai CM, Fan WC, Shih JF, Liu SH, Wu CH, Chou TY, Lee YC, Perng RP, Whang-Peng J.
    J Thorac Oncol; 2012 Feb 01; 7(2):412-8. PubMed ID: 22157367
    [Abstract] [Full Text] [Related]

  • 10. Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
    Gebbia V, Galetta D, Riccardi F, Gridelli C, Durini E, Borsellino N, Gebbia N, Valdesi M, Caruso M, Valenza R, Pezzella G, Colucci G, Gruppo Oncologico Italia Meridionale.
    Lung Cancer; 2002 Aug 01; 37(2):179-87. PubMed ID: 12140141
    [Abstract] [Full Text] [Related]

  • 11. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
    Krzakowski M, Provencio M, Utracka-Hutka B, Villa E, Codes M, Kuten A, Henke M, Lopez M, Bell D, Biti G, Merimsky O, Beorchia A, Riggi M, Caux NR, Pouget JC, Dubray B, David P.
    J Thorac Oncol; 2008 Sep 01; 3(9):994-1002. PubMed ID: 18758302
    [Abstract] [Full Text] [Related]

  • 12. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R, Zatloukal P, Jassem J, Schwarzenberger P, Orlov SV, Gottfried M, Pereira JR, Temperley G, Negro-Vilar R, Rahal S, Zhang JK, Negro-Vilar A, Dziewanowska ZE.
    J Clin Oncol; 2008 Apr 10; 26(11):1886-92. PubMed ID: 18398154
    [Abstract] [Full Text] [Related]

  • 13. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA, Drinkard LC, Hoffman PC, Lane N, Watson S, Samuels BL, Bitran JD, Golomb HM, Vokes EE.
    Cancer J Sci Am; 1995 Apr 10; 1(4):288-94. PubMed ID: 9166490
    [Abstract] [Full Text] [Related]

  • 14. Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B.
    Richards F, Perry DJ, Goutsou M, Modeas C, Muchmore E, Rege V, Chahinian AP, Hirsh V, Poiesz B, Green MR.
    Cancer; 1991 Jun 15; 67(12):2974-9. PubMed ID: 1646066
    [Abstract] [Full Text] [Related]

  • 15. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.
    Douillard JY, Rosell R, De Lena M, Carpagnano F, Ramlau R, Gonzáles-Larriba JL, Grodzki T, Pereira JR, Le Groumellec A, Lorusso V, Clary C, Torres AJ, Dahabreh J, Souquet PJ, Astudillo J, Fournel P, Artal-Cortes A, Jassem J, Koubkova L, His P, Riggi M, Hurteloup P.
    Lancet Oncol; 2006 Sep 15; 7(9):719-27. PubMed ID: 16945766
    [Abstract] [Full Text] [Related]

  • 16. Traditional Chinese medicine herbal treatment may have a relevant impact on the prognosis of patients with stage IV adenocarcinoma of the lung treated with platinum-based chemotherapy or combined targeted therapy and chemotherapy.
    Guo H, Liu JX, Xu L, Madebo T, Baak JP.
    Integr Cancer Ther; 2011 Jun 15; 10(2):127-37. PubMed ID: 21147812
    [Abstract] [Full Text] [Related]

  • 17. A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial.
    Kubota K, Sakai H, Katakami N, Nishio M, Inoue A, Okamoto H, Isobe H, Kunitoh H, Takiguchi Y, Kobayashi K, Nakamura Y, Ohmatsu H, Sugawara S, Minato K, Fukuda M, Yokoyama A, Takeuchi M, Michimae H, Gemma A, Kudoh S, Tokyo Cooperative Oncology Group.
    Ann Oncol; 2015 Jul 15; 26(7):1401-8. PubMed ID: 25908605
    [Abstract] [Full Text] [Related]

  • 18. Randomized phase II study of paclitaxel and carboplatin or vinorelbine in advanced non-small cell lung cancer.
    Jahnke K, Keilholz U, Lüftner D, Thiel E, Schmittel A.
    Anticancer Res; 2011 Jan 15; 31(1):317-23. PubMed ID: 21273617
    [Abstract] [Full Text] [Related]

  • 19. Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin-vinorelbine with a cisplatin-vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study.
    Pérol M, Léna H, Thomas P, Robinet G, Fournel P, Coste E, Belleguic C, Le Caer H, Blanchon F, Vergnenègre A, Vernejoux JM, Schuller-Lebeau MP, Pham E.
    Ann Oncol; 2002 May 15; 13(5):742-7. PubMed ID: 12075743
    [Abstract] [Full Text] [Related]

  • 20. Weekly vinorelbine and paclitaxel in older patients with advanced non-small cell lung cancer: A phase II Fred and Pamela Buffet Cancer Center Clinical Trials Network study.
    Huerter MM, Meza JL, Copur MS, Tolentino A, Marr AS, Ketcham M, DeSpiegelaere H, Kruse S, Kos ME, Swenson K, Radniecki SE, Kessinger A, Ganti AK.
    J Geriatr Oncol; 2017 Jan 15; 8(1):18-22. PubMed ID: 27491498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.